INTERCEPT PHARMACEUTICALS INC 4
4 · INTERCEPT PHARMACEUTICALS INC · Filed Jul 9, 2014
Insider Transaction Report
Form 4
TALLARIGO LORENZO
Director
Transactions
- Exercise/Conversion
Common Stock
2014-07-07$9.82/sh+2,000$19,645→ 2,000 total - Sale
Common Stock
2014-07-07$242.11/sh−1,000$242,110→ 1,000 total - Sale
Common Stock
2014-07-07$244.00/sh−1,000$244,000→ 0 total - Exercise/Conversion
Option to Purchase Common Stock
2014-07-07−2,000→ 4,923 totalExercise: $9.82Exp: 2018-09-18→ Common Stock (2,000 underlying)
Footnotes (2)
- [F1]The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 18, 2013.
- [F2]All shares underlying this option are fully vested.